Features of the influence of atherosclerotic damage of various vascular basins on the risk of development of fatal and non-fatal events in a long period


DOI: https://dx.doi.org/10.18565/therapy.2021.8.70-75

Kobzeva N.D.

Rostov State Medical University of the Ministry of Healthcare of Russia, Rostov-on- Don
Abstract. To date, there is no final opinion on the prognostic significance of risk factors in assessing the severity of the prognosis of patients with multifocal atherosclerosis, and there are no reliable tools for its assessment.
Aim: to study the effect of atherosclerotic lesions of various vascular regions on long-term outcomes during a 3-year prospective follow-up.
Material and methods. The study included 519 patients with lesions of various vascular basins, who were treated in specialized departments, of whom 360 (69,4%) were men, 159 (30,6%) were women. The average age of the examined patients was 60,0±8,7 years.
Results. The study demonstrated that as the number of affected vascular pools increased, the likelihood of developing fatal and non-fatal cases of myocardial infarction and fatal cases of heart failure increased.
Conclusions. An original model is proposed that can be used to predict the risk of vascular events in the long term.

Literature



  1. Dzau V.J., Antman E.M., Black H.R. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions. Circulation. 2006; 114 (25): 2871–91. doi: 10.1161/CIRCULATIONAHA.106.655761.

  2. Копылов В.Ю. Изменение функционального состояния эпителия проксимальных почечных канальцев у лиц с дислипидемией на фоне ожирения, осложненного сахарным диабетом 2-го типа, при приеме симвастатина в аспекте кардиоренального синдрома. Атеросклероз и дислипидемии. 2020; 2: 26–32. [Kopylov V.Yu. Changes in the functional state of the epithelium of the proximal renal tubules in individuals with dyslipidemia associated with obesity complications of type 2 diabetes, when taking simvastatin, in the aspect of cardio-renal syndrome. Ateroskleroz i dislipidemii = Atherosclerosis and dyslipidemia. 2020; 2: 26–32 (In Russ.)]. https://doi.org/10.34687/2219-8202.JAD.2020.02.0004.

  3. Wilson D.P., Jacobson T.A., Jones P.H. et al. Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. J Clin Lipidol. 2019; 13(3): 374–92. doi: 10.1016/j.jacl.2019.04.010.

  4. Кухарчук В.В., Ежов М.В., Сергиенко И.В. с соавт. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации, VII пересмотр. Атеросклероз и дислипидемии. 2020; 1: 7–40. [Kukharchuk V.V., Ezhov M.V., Sergienko I.V. et al. Diagnostics and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian recommendations VII revision. Ateroskleroz i dislipidemii = Atherosclerosis and dyslipidemia. 2020; 1: 7–40 (In Russ.)]. https://doi.org/10.34687/2219-8202.JAD.2020.01.0002.

  5. Баланова Ю.А., Шальнова С.А., Деев А.Д. с соавт. Ожирение в российской популяции – распространенность и ассоциации с факторами риска хронических неинфекционных заболеваний. Российский кардиологический журнал. 2018; 6: 123–130. [Balanova Yu.A., Shalnova S.A., Deev A.D. et al. Obesity in Russian population – prevalence and association with the non-communicable diseases risk factors. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2018; 6: 123–130 (In Russ.)]. https://doi.org/10.15829/1560-4071-2018-6-123-130.

  6. Jang J.J., Bhapkar M., Coles A. et al. PROMISE Investigators. Predictive model for high-risk coronary artery disease. Circ Cardiovasc Imaging. 2019; 12(2): e007940. doi: 10.1161/CIRCIMAGING.118.007940.

  7. Tang W., Shen X., Li H. et al. The independent and incremental value of ultrasound carotid plaque length to predict the presence and severity of coronary artery disease: analysis from the carotid plaque length prospective registry. Eur Heart J Cardiovasc Imaging. 2020; 21(4): 389–96. doi: 10.1093/ ehjci/jez304.

  8. Langsted A., Nordestgaard B.G. Nonfasting versus fasting lipid profile for cardiovascular risk prediction. Pathology. 2019; 51(2): 131–41. doi: 10.1016/j.pathol.2018.09.062.

  9. Кобзева Н.Д., Терентьев В.П., Батюшин М.М., Гасанов М.З. Влияние стеноза почечных артерий в комплексе с другими факторами на риск развития фатальных и нефатальных сосудистых событий у пациентов с острым коронарным синдромом. Терапия. 2018; 3: 60–65. [Kobzeva N.D., Terentiev V.P., Batyushin M.M., Gasanov M.Z. The effect of renal artery stenosis in combination with other risk factors on fatal and nonfatal vascular events in patients with ACS. Terapiya = Therapy. 2018; 3: 60–65 (In Russ.)].

  10. Слатова Л.Н., Щукин Ю.В., Шиляева Н.В. Особенности течения острого коронарного синдрома у пациентов с мультифокальным атеросклерозом. Кардиология: от науки – к практике: материалы Российского национального конгресса кардиологов (г. С.-Петербург, 25–27 сент. 2013 г.). С-Пб. 2013; 503 с. [Slatova L.N., Shchukin Yu.V., Shilyaeva N.V. Features of the course of acute coronary syndrome in patients with multifocal atherosclerosis. Cardiology: from science to practice: materials of the Russian National Congress of Cardiology (Saint Petersburg, 25–27 September 2013). Saint Petersburg. 2013; 503 pp. (In Russ.)].

  11. Ahmed A., Nampoory M.R., Sheikh M., Johny K.V..Renal artery stenosis in patients with peripheral vascular disease in Kuwait Med Princ Pract. 2005; 14(6): 386–89. doi: 10.1159/000088110.

  12. Ponikowski P., Voors A.A., Anker S.D. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129–200. doi: 10.1093/eurheartj/ehw128.

  13. Яхонтов Д.А., Останина Ю.О., Пахарукова М.Ю., Мордвинова В.А. Клиническая характеристика и проявления мультифокального атеросклероза у больных ИБС различных возрастных групп. Комплексные проблемы сердечно-сосудистых заболеваний. 2017; 4: 36–43. [Yakhontov D.A., Ostanina Yu.O., Pakharukova M.Yu., Mordvinov V.A. Clinical sings and symptoms of polyvascular disease in coronary artery disease patients of different age groups. Kompleksnye problemy serdechno-sosudistykh zabolevaniy = Complex Issues of Cardiovascular Diseases. 2017; 4: 36–43 (In Russ.)]. https://doi.org/10.17802/2306-1278-2017-6-4-36-43.


About the Autors


Natalia D. Kobzeva, PhD, assistant at the Department of internal medicine No. 1, Rostov State Medical University of the Ministry of Healthcare of Russia. Address: 344022, Rostov-on-Don, 29 Nakhicevansky Lane.
E-mail: kobzeva.nataliya1@gmail.com. ORCID: 0000-0002-3390-2452


Similar Articles


Бионика Медиа